成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
武漢敬康恩生物醫(yī)藥科技有限公司 Company Information
Company Name:
Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel:
13720134139 +86 -0-15871494362
Email:
orders@jknbiochem.com
Nationality:
China
WebSite:
www.jknbiochem.com
Product List:
5821
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
Product List
Deflazacort
14484-47-0
prednisolon
50-24-8
11α-Hydroxyprogesterone
80-75-1
Fludrocortisone acetate
514-36-3
Hydrocortisone 17-valerate
57524-89-7
cortisol sodium phosphate
6000-74-4
Hydrocortisone-17-butyrate
13609-67-1
Triamcinolone Acetonide EP Impurity E
1524-86-3
triamcinolone acetonide
76-25-5
Triamcinolone
124-94-7
Budesonide
51372-29-3
Gepotidacin
1075236-89-3
Hydrocortisone Sodium Succinate
125-04-2
Cortisone
53-06-5
BEMPEDOIC ACID
738606-46-7
Prednisolone Hemisuccinate
2920-86-7
Difluprednate
23674-86-4
loteprednol etabonate
82034-46-6
Prednisolone Valeroacetate
72064-79-0
Prednisolone phosphate sodium
125-02-0
Prednisone Phosphate Disodium Salt/17-Hydroxy-21-(phosphonooxy)pregna-1,4-diene-3,11,20-trione disodium salt
33903-70-7
Anecortave Acetate
7753-60-8
Clascoterone
19608-29-8
ZN-c3
2376146-48-2
Fmoc-N'-methyltrityl-L-lysine
167393-62-6
1H-1,4-Benzodiazepine-2-methanamine, 7-chloro-2,3-dihydro-5-phenyl-
138729-68-7
NA
58468-07-4
MK-1775
955365-80-7
IAG933
2714434-21-4
8H-[1,4]Diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one, 3-[[2-chloro-5-(ethoxymethyl)-4-pyrimidinyl]oxy]-9,10,11,12-tetrahydro-10-methyl-, (10R)-
1887069-10-4
Bermekimab
1401965-15-8
Research Grade Nemolizumab
1476039-58-3
Isatuximab
1461640-62-9
Lilotomab
1453362-55-4
Indusatumab
1497400-26-6
Navivumab
1443004-16-7
Pepinemab
2097151-87-4
Obiltoxaximab
1351337-07-9
Rovalpituzumab
1613313-01-1
Istiratumab
1509928-04-4
Research Grade Cergutuzumab
1509916-03-3
Trevogrumab
1429201-24-0
Inebilizumab
1299440-37-1
Brolucizumab
1531589-13-5
Tesidolumab
1531594-08-7
Elgemtumab
1512559-37-3
Andecaliximab
1518996-49-0
Indusatumab Vedotin
1514889-12-3
Sevirumab
138660-96-5
4-[4-(4-amino-1,2,5-oxadiazol-3-yl)-2-oxido-1,2,5-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine
296244-55-8
Meplazumab
2413715-21-4
Rinucumab
1569263-06-4
Depatuxizumab
1471999-69-5
Suptavumab
1629615-23-1
Birtamimab
1608108-91-3
Erenumab
1582205-90-0
Fremanezumab
1655501-53-3
Burosumab
1610833-03-8
Eptinezumab
1644539-04-7
Elezanumab
1791416-49-3
Afasevikumab
1589503-30-9
Tisotumab
1418628-81-5
Landogrozumab
1391726-30-9
Tilavonemab
2096513-89-0
Research Grade Ifabotuzumab
1234137-51-9
Tezepelumab
1572943-04-4
Olendalizumab
1337966-73-0
Research Grade Gontivimab
1257358-38-5
Satralizumab
1535963-91-7
Xentuzumab
1417158-65-6
Refanezumab
1233953-61-1
Enoblituzumab
1353485-38-7
Cabiralizumab
1613144-80-1
Ascrinvacumab
1463459-96-2
Monalizumab
1228763-95-8
Plozalizumab
1610761-46-0
Bleselumab
1453067-91-8
Opicinumab
1422268-07-2
Clivatuzumab Tetraxetan
1462876-11-4
Mirvetuximab
1453084-36-0
Navicixizumab
1638338-43-8
Prezalumab
1523164-68-2
Laprituximab
1622327-38-1
Naratuximab
1622327-39-2
Vadastuximab
1436390-63-4
Rivabazumab
1627519-84-9
Tamtuvetmab
1608122-71-9
Blontuvetmab
1608112-78-2
Crotedumab
1452387-69-7
Vonlerolizumab
1638935-72-4
Lanadelumab
1426055-14-2
Timolumab
1073538-99-4
Carotuximab
1268714-50-6
Domagrozumab
1629605-31-7
Galcanezumab
1578199-75-3
Research Grade Setrusumab
1847394-95-9
Research Grade Apamistamab
2097132-02-8
Duvortuxizumab
1831098-91-9
Rozanolixizumab
1584645-37-3
Lupartumab
1640971-88-5
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
Copyright 2007© ChemicalBook. All rights reserved.